Supply Chain Intelligence about:

Cadila Healthcare Ltd.

Perfil de la empresa

India

See Cadila Healthcare Ltd.'s products and customers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Solicite una Demostración

Fácil acceso a los datos del comercio

Explore trading relationships hidden in supply chain data

Contact information for Cadila Healthcare Ltd.

Dirección

ZYDUS CORPORATE PARK,SCHEME NO.63, SURVEY NO. 536,KHORAJ(GANDHINAGAR), NR. VAISHNODEVI CIRCLE, AHMEDABAD GANDHINAGAR - 382481 INDIA

Top HS Codes

See more goods shipped on Panjiva

Recent Panjiva Research about Cadila Healthcare Ltd.

Mylan Shows Aurobindo The Way as Pharma Gets Left Behind in India’s Export Revival

October 4, 2017

The pharmaceutical industry represents India’s third largest export sector, accounting for 6% of exports in the past year. It’s been in decline, with shipments sliding 1% in dollar terms in the past year. The sector has also lagged the recent recovery in national exports. Volumes shipped have ... Read more →

Lamotrigine Leads AC Drug Import Growth, GSK Doesn’t Gain

November 21, 2016

U.S. imports of anticonvulsant drugs (AC), used for epilepsy, migraine and bipolar treatments, climbed 42% in October, the 18th straight increase. This was led by lamotrigine which jumped 150%. Generic drugmakers including Aurobindo Pharma, Cipla and Cadila have taken the lion’s share of the g... Read more →

Topiramate Tops Anticonvulsant Drug Import Growth in September

October 20, 2016

U.S. imports of anticonvulsant drugs increased 37% on a year earlier in the third quarter, Panjiva data shows. Generic versions of Johnson & Johnson’s Topamax led the way, with a 206% increase perhaps following approval for use in adolescent migraines. Around 80% of generic anticonvulsants exp... Read more →

Miles de emprezas usan Panjiva para buscar proveedores y competidores.